US 9573953
Heteroaromatic compounds as PI3 kinase modulators and methods of use
granted A61KA61K31/444A61K31/4545
Quick answer
US patent 9573953 (Heteroaromatic compounds as PI3 kinase modulators and methods of use) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/444, A61K31/4545, A61K31/519, A61K45/06